Organization
Oncolytics Biotech Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Oncolytics Biotech Inc.
... ANNOUNCEMENT [Text] CALGARY and SAN DIEGO, CA, Nov. 16, 2017 /PRNewswire/ - Oncolytics Biotech(Registered) Inc. (TSX: ONC) (OTCQX: ONCYF) (Oncolytics or the Company), a biotech ...
... achievement of clinical, regulatory and commercialization milestonesUpon Adlai Nortye's commercialization of REOLYSIN®, Oncolytics is eligible to receive double digit royalty paymentsManagement to host webcast and ...
... cobalt. Active today includes: Freeport-McMoRan (NYSE: FCX), Micron Technologies (NYSE: MU), Oncolytics Biotech (TSX: ONC), Scotts Miracle-Gro (NYSE: SMG), America Movil (NYSE: AMX) Cobalt demand ...
... CANADIAN DAILY STOCK REPORT Oncolytics Biotech Inc. (TSX:ONC), Canada's 18th largest Biotechnology company by market cap, has decreased ...
... ANNOUNCEMENT [Text] CALGARY, and SAN DIEGO, CA, Nov. 8, 2017 /CNW/ - Oncolytics Biotech(Registered) Inc. (TSX: ONC) (OTCQX: ONCYF) (Oncolytics or the Company), a biotech ...
... Oncolytics Biotech® Inc. (TSX: ONC) (OTCQX: ONCYF) (Oncolytics or the Company), a biotech company ...
... CANADIAN DAILY STOCK REPORT Oncolytics Biotech Inc. (TSX:ONC), Canada's 19th largest Biotechnology company by market cap, has increased ...
... CANADIAN DAILY STOCK REPORT Corporate Wire Date: 03 November 2017 03:21 EDT Oncolytics Biotech has appointed Deborah M. Brown as a Director. The effective date ...
... Oncolytics Biotech® Inc. (TSX: ONC) (OTCQX: ONCYF) (Oncolytics or the Company), a biotech company ...
... CANADIAN DAILY STOCK REPORT Oncolytics Biotech Inc. (TSX:ONC), Canada's 17th largest Biotechnology company by market cap, has lifted ...
... CANADIAN DAILY STOCK REPORT Oncolytics Biotech Inc. (TSX:ONC), Canada's 17th largest Biotechnology company by market cap, extended its ...
... CANADIAN DAILY STOCK REPORT Oncolytics Biotech Inc. (TSX:ONC), Canada's 19th largest Biotechnology company by market cap, has decreased ...
... CANADIAN WEEKLY STOCK REPORT Oncolytics Biotech Inc. (TSX:ONC) fell for a second week on Friday bringing its a ...
... CANADIAN DAILY STOCK REPORT Oncolytics Biotech Inc. (TSX:ONC), Canada's 17th largest Biotechnology company by market cap, has dropped ...
... data of REOLYSIN®in metastatic breast cancer and the Company's strategic objectives Oncolytics Biotech® Inc. (TSX: ONC) (OTCQX: ONCYF), a biotech company developing REOLYSIN®, a first-in-class, ...
... CANADIAN DAILY STOCK REPORT Oncolytics Biotech Inc. (TSX:ONC), Canada's 17th largest Biotechnology company by market cap, has dropped ...
... CANADIAN WEEKLY STOCK REPORT Oncolytics Biotech Inc. (TSX:ONC), Canada's 17th largest Biotechnology company by market cap, has increased ...
... CANADIAN DAILY STOCK REPORT Corporate Wire Date: 05 October 2017 03:00 EDT Oncolytics Biotech (Canadian:ONC) director Angela Holtham, has been granted restricted share units on ...
... CANADIAN DAILY STOCK REPORT Oncolytics Biotech Inc. (TSX:ONC), Canada's 18th largest Biotechnology company by market cap, has increased ...
... CANADIAN MONTHLY STOCK REPORT Oncolytics Biotech (TSX:ONC), Canada's 17th largest Biotechnology company by market cap, extended its gains ...
... CANADIAN DAILY STOCK REPORT Oncolytics Biotech Inc. (TSX:ONC), Canada's 16th largest Biotechnology company by market cap, has sunk ...
... [Text] CALGARY and SAN DIEGO, Sept. 18, 2017 /PRNewswire/ - Oncolytics Biotech Inc. (TSX: ONC) (OTCQX: ONCYF) (Oncolytics or the Company), a biotech company developing ...
... Dr. Andres Gutierrez, Oncolytics' Chief Medical Officer, to present on the clinical progress and robust safety ...
... CANADIAN DAILY STOCK REPORT Oncolytics Biotech Inc. (TSX:ONC), Canada's 16th largest Biotechnology company by market cap, has soared ...
... effective doubling of median overall survival from 10.8 to 21.0 months Oncolytics Biotech® Inc. (TSX: ONC) (OTCQX: ONCYF) (Oncolytics or the Company), a biotech company ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤